Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe Cases.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
22 Sep 2022
Historique:
pubmed: 2 6 2022
medline: 24 9 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Factors associated with mortality are important in the treatment of coronavirus disease 2019 (COVID-19). Polymerase chain reaction (PCR) is the gold standard for diagnosing COVID-19, which reflects the viral load in the upper respiratory tract. In total, 523 patients were enrolled in this study; of them, 441 and 75 patients underwent PCR testing of nasopharyngeal swabs and sputum samples, respectively, within 20 days from onset of COVID-19. We investigated the association between RNA copy number and the COVID-19 severity and mortality rate and its effect on the predictive performance for severity and mortality. RNA copy numbers in nasopharyngeal swabs were higher in the non-survivor group than in the survivor group. Multivariate logistic regression analysis identified that the high RNA copy number (≥9 log

Identifiants

pubmed: 35650037
doi: 10.7883/yoken.JJID.2022.080
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

504-510

Auteurs

Takahiro Mitsumura (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Tsukasa Okamoto (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.
Department of Pulmonary Immunotherapeutics, Tokyo Medical and Dental University, Japan.

Mizuho Tosaka (M)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Takashi Yamana (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Sho Shimada (S)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Yuki Iijima (Y)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Rie Sakakibara (R)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Sho Shibata (S)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Takayuki Honda (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Tsuyoshi Shirai (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Masahiro Ishizuka (M)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Junichi Aiboshi (J)

Trauma and Acute Critical Care Center, Tokyo Medical and Dental University, Japan.

Haruhiko Furusawa (H)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Tomoya Tateishi (T)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Meiyo Tamaoka (M)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Hidenobu Shigemitsu (H)

Department of Intensive Care Medicine, Tokyo Medical and Dental University, Japan.

Hirokuni Arai (H)

Department of Cardiovascular Surgery, Tokyo Medical and Dental University, Japan.

Yasuhiro Otomo (Y)

Trauma and Acute Critical Care Center, Tokyo Medical and Dental University, Japan.

Shuji Tohda (S)

Department of Laboratory Medicine, Tokyo Medical and Dental University, Japan.

Tatsuhiko Anzai (T)

Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Japan.

Kunihiko Takahashi (K)

Department of Biostatistics, M&D Data Science Center, Tokyo Medical and Dental University, Japan.

Shinsuke Yasuda (S)

Department of Rheumatology, Tokyo Medical and Dental University, Japan.

Yasunari Miyazaki (Y)

Department of Respiratory Medicine, Tokyo Medical and Dental University, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH